Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted
Page 1 of 1
Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted
Jon Moulton Mon Jan 10, 2011 1:30 pm
Liu G, Dou S, Chen X, Chen L, Liu X, Rusckowski M, Hnatowich DJ. Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted. Cancer Biother Radiopharm. 2010 Dec;25(6):757-62.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» The ratio of maximum percent tumor accumulations of the pretargeting agent and the radiolabeled effector is independent of tumor size
» A Clearance Step will become Increasingly Crucial for Pretargeted Tumor Therapy when Tumor Accumulation is Improved
» A preclinical (188) Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49
» Amotl2a interacts with the Hippo effector Yap1 and the Wnt/β-catenin effector Lef1 to control tissue size in zebrafish
» An equation to estimate the difference between theoretically predicted and SDS PAGE-displayed molecular weights for an acidic peptide
» A Clearance Step will become Increasingly Crucial for Pretargeted Tumor Therapy when Tumor Accumulation is Improved
» A preclinical (188) Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49
» Amotl2a interacts with the Hippo effector Yap1 and the Wnt/β-catenin effector Lef1 to control tissue size in zebrafish
» An equation to estimate the difference between theoretically predicted and SDS PAGE-displayed molecular weights for an acidic peptide
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum